CORTICOSTEROID SPARING EFFECTS OF USTEKINUMAB THERAPY FOR ULCERATIVE COLITIS THROUGH 2 YEARS: UNIFI LONG-TERM EXTENSION

被引：0
|
作者：
Sandborn, William J.
Peyrin-Biroulet, Laurent
Sands, Bruce E.
Scherl, Ellen J.
Marano, Colleen W.
O'Brien, Christopher D.
Zhang, Hongyan
Johanns, Jewel
Zhou, Yiying
Abreu, Maria T.
Arasaradnam, Ramesh P.
Rowbotham, David
Leong, Rupert W.
Danese, Silvio
机构：
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1851
引用
收藏
页码：S1187 / S1188
页数：2
相关论文
共 50 条
  • [1] Corticosteroid sparing effects of ustekinumab therapy for ulcerative colitis through 2 years: UNIFI long-term extension
    Peyrin-Biroulet, L.
    Sandborn, W.
    Sands, B.
    Scherl, E.
    Marano, C.
    O'Brien, C.
    Zhang, H.
    Johanns, J.
    Zhou, Y.
    Abreu, M.
    Arasaradnam, R. P.
    Rowbotham, D. S.
    Leong, R. W. L.
    Danese, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S113 - S114
  • [2] Corticosteroid-Sparing Effects of Ustekinumab Therapy for Ulcerative Colitis Through 4 Years: UNIFI Long-Term Extension
    Abreu, Maria T.
    Scherl, Ellen J.
    Rowbotham, David S.
    Danese, Silvio
    Sandborn, William J.
    Miao, Ye
    Zhang, Hongyan
    Panaccione, Remo
    Afif, Waqqas
    Hisamatsu, Tadakazu
    Leong, Rupert W.
    Sands, Bruce E.
    Arasaradnam, Ramesh P.
    Marano, Colleen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S577 - S577
  • [3] Corticosteroid-sparing effects of ustekinumab therapy for Ulcerative Colitis through 3 years: UNIFI long-term extension
    Scherl, E. J.
    Rowbotham, D. S.
    Danese, S.
    Sandborn, W. J.
    Miao, Y.
    Zhang, H.
    Abreu, M. T.
    Panaccione, R.
    Afif, W.
    Hisamatsu, T.
    Leong, R. W.
    Arasaradnam, R. P.
    Sands, B. E.
    Marano, C.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S117 - S118
  • [4] Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension
    Abreu, M. T.
    Danese, S.
    Sandborn, W. J.
    Miao, Y.
    Tikhonov, I.
    Zhang, H.
    Panacciones, R.
    Hisamatsu, T.
    Scherl, E. J.
    Leong, R. W.
    Rowbotham, D. S.
    Arasaradnam, R. P.
    Afif, W.
    Peyrin-Biroulet, L.
    Sands, B. E.
    Marano, C.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S113 - S114
  • [5] Efficacy of Ustekinumab for Ulcerative Colitis in Patients Through 3 Years: UNIFI Long-term Extension
    Abreu, Maria T.
    Rowbotham, David S.
    Danese, Silvio
    Sandborn, William J.
    Miao, Ye
    Zhang, Hongyan
    Panaccione, Remo
    Hisamatsu, Tadakazu
    Scherl, Ellen
    Leong, Rupert
    Arasaradnam, Ramesh
    Afif, Waqqas
    Peyrin-Biroulet, Laurent
    Sands, Bruce E.
    Marano, Colleen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S315 - S315
  • [6] Efficacy of ustekinumab for ulcerative colitis through 2 years: Results of the UNIFI maintenance study and long-term extension
    Panaccione, R.
    Sandborn, W. J.
    Sands, B. E.
    Marano, C.
    O'Brien, C. D.
    Zhang, H.
    Johanns, J.
    Zhou, Y.
    Peyrin-Biroulet, L.
    Hisamatsu, T.
    Danese, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S049 - S049
  • [7] EFFICACY OF USTEKINUMAB FOR ULCERATIVE COLITIS THROUGH 2 YEARS: RESULTS OF THE UNIFI MAINTENANCE STUDY AND LONG-TERM EXTENSION
    Sandborn, William J.
    Sands, Bruce E.
    Panaccione, Remo
    Marano, Colleen W.
    O'Brien, Christopher D.
    Zhang, Hongyan
    Johanns, Jewel
    Zhou, Yiying
    Peyrin-Biroulet, Laurent
    Hisamatsu, Tadakazu
    Danese, Silvio
    GASTROENTEROLOGY, 2020, 158 (06) : S1186 - S1186
  • [8] Efficacy and Safety of Maintenance Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension
    Abreu, Maria T.
    Rowbotham, David S.
    Danese, Silvio
    Sandborn, William J.
    Miao, Ye
    Zhang, Hongyan
    Tikhonov, Ilia
    Panaccione, Remo
    Hisamatsu, Tadakazu
    Scherl, Ellen J.
    Leong, Rupert W.
    Arasaradnam, Ramesh P.
    Afif, Waqqas
    Peyrin-Biroulet, Laurent
    Sands, Bruce E.
    Marano, Colleen
    JOURNAL OF CROHNS & COLITIS, 2022, 16 (08): : 1222 - 1234
  • [9] Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 4 Years: Final Results From the UNIFI Long-Term Extension
    Sands, Bruce E.
    Abreu, Maria T.
    Danese, Silvio
    Sandborn, William J.
    Miao, Ye
    Zhang, Hongyan
    Panaccione, Remo
    Hisamatsu, Tadakazu
    Scherl, Ellen J.
    Leong, Rupert W.
    Rowbotham, David S.
    Arasaradnam, Ramesh P.
    Peyrin-Biroulet, Laurent
    Afif, Waqqas
    Marano, Colleen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S525 - S526
  • [10] Efficacy of ustekinumab for Ulcerative Colitis through 4 years: Final clinical and endoscopy outcomes from the UNIFI long-term extension
    Danese, S.
    Afif, W.
    Abreu, M.
    Sandborn, W.
    Miao, Y.
    Zhang, H.
    Panaccione, R.
    Hisamatsu, T.
    Scherl, E.
    Leong, R.
    Rowbotham, D.
    Arasaradnam, R.
    Peyrin-Biroulet, L.
    Sands, B.
    Marano, C.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I19 - I20
12345